Psychometrics and normative data for the Multiple Sclerosis Functional Composite: replacing the PASAT with the Symbol Digit Modalities Test
- PMID: 20028710
- DOI: 10.1177/1352458509354552
Psychometrics and normative data for the Multiple Sclerosis Functional Composite: replacing the PASAT with the Symbol Digit Modalities Test
Abstract
The MS Functional Composite (MSFC) is a continuous scale of neurological disability for patients with multiple sclerosis (MS). Cognition is represented by the Paced Auditory Serial Addition Test (PASAT), although the Symbol Digit Modalities Test (SDMT) has been proposed as a promising alternative. MSFC scores were calculated using either the PASAT or the SDMT with the following reference populations: National Multiple Sclerosis Society (NMSS) Task Force, 400 MS patients, and 100 normal controls. A subgroup of 115 patients was followed longitudinally, with a test-retest interval of 2.3 +/- 1.2 years. Pearson correlations were calculated and analyses of variance (ANOVAs) were used to assess relationships among the MSFC components and composite scores, and differences in performance between patients and controls. Longitudinal changes were also assessed. Logistic regression was performed to determine which MSFC scores are most predictive of diagnosis, course, and work disability. All MSFCs had similar test-retest reliability and correlations with other measures including neurological disability, depression, and fatigue. The SDMT showed slightly better validity with respect to predicting diagnosis, course, and work disability, although the amount of variance accounted for was similar for each version of the MSFC. Our data, derived from a large sample of MS patients and normal controls, supports the validity of both PASAT and SDMT versions of the MSFC. Because the SDMT has slightly better predictive validity and has a relatively easier administration procedure, some clinicians and researchers may wish to replace the PASAT with the SDMT in future calculations of the MSFC using the calculation methods provided in this manuscript.
Similar articles
-
Should SDMT substitute for PASAT in MSFC? A 5-year longitudinal study.Mult Scler. 2008 Nov;14(9):1242-9. doi: 10.1177/1352458508094398. Epub 2008 Jul 24. Mult Scler. 2008. PMID: 18653737
-
Paced visual serial addition test in multiple sclerosis.Clin Neurol Neurosurg. 2005 Apr;107(3):218-22. doi: 10.1016/j.clineuro.2004.11.016. Clin Neurol Neurosurg. 2005. PMID: 15823678 Clinical Trial.
-
[Sleepiness and fatigue in multiple sclerosis - comparison of different measuring instruments].Fortschr Neurol Psychiatr. 2003 Nov;71(11):590-4. doi: 10.1055/s-2003-43464. Fortschr Neurol Psychiatr. 2003. PMID: 14608510 Clinical Trial. German.
-
Cognitive impairment and decline in different MS subtypes.J Neurol Sci. 2006 Jun 15;245(1-2):187-94. doi: 10.1016/j.jns.2005.07.018. Epub 2006 Apr 27. J Neurol Sci. 2006. PMID: 16643951 Review.
-
The multiple sclerosis functional composite: a clinically meaningful measure of disability.Neurology. 2010 Apr 27;74 Suppl 3:S8-15. doi: 10.1212/WNL.0b013e3181dbb571. Neurology. 2010. PMID: 20421572 Review.
Cited by
-
Normal-appearing white matter permeability distinguishes poor cognitive performance in processing speed and working memory.AJNR Am J Neuroradiol. 2013 Nov-Dec;34(11):2119-24. doi: 10.3174/ajnr.A3539. Epub 2013 May 30. AJNR Am J Neuroradiol. 2013. PMID: 23721894 Free PMC article.
-
Loneliness, Depressive Symptoms, and Cognitive Functioning Among U.S. Chinese Older Adults.Gerontol Geriatr Med. 2018 Jul 17;4:2333721418778201. doi: 10.1177/2333721418778201. eCollection 2018 Jan-Dec. Gerontol Geriatr Med. 2018. PMID: 30038951 Free PMC article.
-
OzEAN Study to Collect Real-World Evidence of Persistent Use, Effectiveness, and Safety of Ozanimod Over 5 Years in Patients With Relapsing-Remitting Multiple Sclerosis in Germany.Front Neurol. 2022 Jun 27;13:913616. doi: 10.3389/fneur.2022.913616. eCollection 2022. Front Neurol. 2022. PMID: 35832177 Free PMC article.
-
Gait abnormalities in multiple sclerosis: pathogenesis, evaluation, and advances in treatment.Curr Neurol Neurosci Rep. 2011 Oct;11(5):507-15. doi: 10.1007/s11910-011-0214-y. Curr Neurol Neurosci Rep. 2011. PMID: 21779953
-
A comparison of the brief international cognitive assessment for multiple sclerosis and the brief repeatable battery in multiple sclerosis patients.BMC Neurol. 2015 Oct 15;15:204. doi: 10.1186/s12883-015-0460-8. BMC Neurol. 2015. PMID: 26472052 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical